0001042074-13-000003.txt : 20131011 0001042074-13-000003.hdr.sgml : 20131011 20131011151119 ACCESSION NUMBER: 0001042074-13-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20131011 DATE AS OF CHANGE: 20131011 EFFECTIVENESS DATE: 20131011 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc. CENTRAL INDEX KEY: 0001042074 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943103561 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-204453 FILM NUMBER: 131147851 BUSINESS ADDRESS: STREET 1: 3876 BAY CENTER PLACE CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 510-293-8800 MAIL ADDRESS: STREET 1: 3876 BAY CENTER PLACE CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX, INC. DATE OF NAME CHANGE: 20090721 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX INC DATE OF NAME CHANGE: 19970710 D 1 primary_doc.xml X0707 D LIVE 0001042074 CymaBay Therapeutics, Inc. 3876 BAY CENTER PLACE HAYWARD CA CALIFORNIA 94545 510-293-8800 DELAWARE METABOLEX, INC. METABOLEX INC Corporation true Harold Van Wart, Ph. D. 3876 Bay Center Place Hayward CA CALIFORNIA 94545 Executive Officer Director Charles A. McWherter, Ph. D. 3876 Bay Center Place Hayward CA CALIFORNIA 94545 Executive Officer Sujal Shah 3876 Bay Center Place Hayward CA CALIFORNIA 94545 Executive Officer Louis G. Lange, M.D., Ph.D. 3876 Bay Center Place Hayward CA CALIFORNIA 94545 Director Kurt von Emster 3876 Bay Center Place Hayward CA CALIFORNIA 94545 Director Carl Goldfischer, M.D. 3876 Bay Center Place Hayward CA CALIFORNIA 94545 Director Hari Kumar, Ph.D. 3876 Bay Center Place Hayward CA CALIFORNIA 94545 Director Edward E. Penhoet, Ph.D. 3876 Bay Center Place Hayward CA CALIFORNIA 94545 Director Biotechnology Decline to Disclose 06c false 2013-09-30 false true true true false 0 National Securities Corporation 7569 Hany Samir Awadalla, Managing Director 2074306 410 Park Avenue, 14th Floor New York NY NEW YORK 10022 All States false 45000000 26833640 18166360 The amount of the offering and the amount sold do not include the shares sold in connection with the conversion of debt in the amount of $16,900,000. false 264 1821799 true 0 0 Working capital and general corporate purposes. false CymaBay Therapeutics, Inc. /s/ Sujal Shah Sujal Shah Acting Chief Financial Officer 2013-10-11